IA
ANIP icon

IFP Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

IFP Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83 Hold
1
– – ﹤0.01% 4980
2026
Q1 		$77 Hold
1
– – ﹤0.01% 4780
2025
Q4 		$79 Hold
1
– – ﹤0.01% 4640
2025
Q3 		$92 Buy
+1
New +$82 ﹤0.01% 4555
2025
Q2 		– Hold
0
– – – 4250
2025
Q1 		– Hold
0
– – – 3781
2024
Q4 		– Hold
0
– – – 3992
2020
Q1 		– Sell
-54
Closed -$2.87K – 2762
2019
Q4 		$3K Buy
54
+7
+15% +$464 ﹤0.01% 2341
2019
Q3 		$3K Buy
+47
New +$3.52K ﹤0.01% 2502
2019
Q1 		– Sell
-75
Closed -$3K – 2393
2018
Q4 		$3K Sell
75
-24
-24% -$1.26K ﹤0.01% 3009
2018
Q3 		$6K Buy
99
+17
+21% +$1.04K ﹤0.01% 3105
2018
Q2 		$5K Sell
82
-43
-34% -$2.68K ﹤0.01% 3226
2018
Q1 		$8K Hold
125
– – ﹤0.01% 2901
2017
Q4 		$8K Sell
125
-26
-17% -$1.62K ﹤0.01% 2946
2017
Q3 		$8K Hold
151
– – ﹤0.01% 3129
2017
Q2 		$7K Buy
151
+16
+12% +$772 ﹤0.01% 3208
2017
Q1 		$7K Buy
135
+18
+15% +$1.01K ﹤0.01% 3096
2016
Q4 		$7K Hold
117
– – ﹤0.01% 3095
2016
Q3 		$8K Buy
117
+100
+588% +$6.25K ﹤0.01% 2948
2016
Q2 		$1K Buy
+17
New +$826 ﹤0.01% 3576
2016
Q1 		– Sell
-17
Closed -$1K – 2398
2015
Q4 		$1K Buy
+17
New +$732 ﹤0.01% 3474

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IFP Advisors's ANIP Position: Q2 2026 in Review

IFP Advisors held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 1 share worth $83. The position accounts for ﹤0.01% of the portfolio, ranked #4980.

IFP Advisors first reported a position in ANIP in Q4 2015 and has held it in 18 quarters since. The position peaked at $8K in Q1 2018. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • IFP Advisors held 1 share of ANI Pharmaceuticals worth $83 as of Q2 2026.
  • IFP Advisors left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4980 holding.
  • IFP Advisors first reported a position in ANI Pharmaceuticals in Q4 2015 and has held it in 18 quarters since.
  • IFP Advisors's ANI Pharmaceuticals position peaked at $8K in Q1 2018.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.